CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Clinical Investigation

• Publication date

  2010-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI40665PMID 20335658PMCID PMC2846051
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chromodomain helicase/adenosine triphosphatase DNA binding protein 1–like (CHD1l) gene suppresses the nucleus‐to‐mitochondria translocation of nur77 to sustain hepatocellular carcinoma cell survival

  2009cited by this paper
• Progesterone regulation of RUSH/SMARCA3/HLTF includes DNA looping.

  2008cited by this paper
• Rho GTPases in cancer cell biology

  2008cited by this paper
• Different expression of apoptotic proteins between HBV-infected and non-HBV-infected hepatocellular carcinoma.

  2007cited by this paper
• The significance of proline-rich tyrosine kinase2 (Pyk2) on hepatocellular carcinoma progression and recurrence

  2007cited by this paper
• Isolation and characterization of a novel oncogene, amplified in liver cancer 1, within a commonly amplified region at 1q21 in hepatocellular carcinoma

  2007influential reference
• Is Autotaxin (ENPP2) the Link between Hepatitis C and Hepatocellular Cancer?

  2007cited by this paper
• Clusterin plays an important role in hepatocellular carcinoma metastasis

  2006cited by this paper
• Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton.

  2006cited by this paper
• Twist Overexpression Correlates with Hepatocellular Carcinoma Metastasis through Induction of Epithelial-Mesenchymal Transition

  2006cited by this paper
• Complex networks orchestrate epithelial–mesenchymal transitions

  2006cited by this paper
• HTPAP gene on chromosome 8p is a candidate metastasis suppressor for human hepatocellular carcinoma

  2006cited by this paper
• MatInspector and beyond: promoter analysis based on transcription factor binding sites

  2005cited by this paper
• Rho GTPases and the control of cell behaviour.

  2005cited by this paper
• A chromatin immunoprecipitation screen reveals protein kinase Cbeta as a direct RUNX1 target gene.

  2004cited by this paper
• Epithelial-mesenchymal transitions: twist in development and metastasis.

  2004cited by this paper
• Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver.

  2004cited by this paper
• Overexpression of cortactin is involved in motility and metastasis of hepatocellular carcinoma.

  2004cited by this paper
• A Chromatin Immunoprecipitation Screen Reveals Protein Kinase Cβ as a Direct RUNX1 Target Gene*

  2004cited by this paper
• Allelic alterations in nontumorous liver tissues and corresponding hepatocellular carcinomas from chinese patients.

  2003cited by this paper
• Tumour-cell invasion and migration: diversity and escape mechanisms

  2003cited by this paper
• Positional mapping for amplified DNA sequences on 1q21-q22 in hepatocellular carcinoma indicates candidate genes over-expression.

  2003cited by this paper
• The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited

  2003cited by this paper
• Relation between the rate of tumour cell proliferation and latency time in radiation associated breast cancer

  2003cited by this paper
• Tumor progression: Small GTPases and loss of cell-cell adhesion.

  2003cited by this paper
• Molecular pathogenesis of human hepatocellular carcinoma

  2002cited by this paper
• Epithelial–mesenchymal transitions in tumour progression

  2002cited by this paper
• RHO–GTPases and cancer

  2002cited by this paper
• Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters

  2002cited by this paper
• Prognostic significance of c‐myc and AIB1 amplification in hepatocellular carcinoma

  2002cited by this paper
• Sub-lethal radiation enhances anti-tumor immunotherapy in a transgenic mouse model of pancreatic cancer

  2002cited by this paper
• Cell-cell adhesion and signalling.

  2002cited by this paper
• Tiam1 Overexpression Potentiates Heregulin-induced Lymphoid Enhancer Factor-1/β-Catenin Nuclear Signaling in Breast Cancer Cells by Modulating the Intercellular Stability*

  2001cited by this paper
• Isolation of a novel candidate oncogene within a frequently amplified region at 3q26 in ovarian cancer.

  2001cited by this paper
• Motility‐Related Proteins as Markers for Head and Neck Squamous Cell Cancer

  2001cited by this paper
• Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization

  2000cited by this paper
• P120 Catenin Regulates the Actin Cytoskeleton via Rho Family Gtpases

  2000cited by this paper
• Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma.

  2000cited by this paper
• Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization

  2000cited by this paper
• The association of chromosome 8p deletion and tumor metastasis in human hepatocellular carcinoma.

  1999cited by this paper
• Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis.

  1999cited by this paper
• Identification and Characterization of hPEM-2, a Guanine Nucleotide Exchange Factor Specific for Cdc42*

  1999cited by this paper
• Rho GTPases and the actin cytoskeleton.

  1998cited by this paper
• Characterization of the CHD family of proteins.

  1997cited by this paper
• SWI2/SNF2 and related proteins: ATP-driven motors that disrupt protein-DNA interactions?

  1997cited by this paper
• Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization

  1997cited by this paper
• Rho GTPases and signaling networks.

  1997cited by this paper
• Evolution of the SNF2 family of proteins: subfamilies with distinct sequences and functions.

  1995cited by this paper
• Overexpression and point mutations of p53 tumor suppressor gene in hepatocellular carcinomas in Hong Kong Chinese people

  1994cited by this paper
• Identification of an invasion-inducing gene, Tiam-1, that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteins.

  1994cited by this paper
• Proteins regulating Ras and its relatives

  1993cited by this paper
• Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma.

  1990cited by this paper

• CHD1L in cancer and beyond: structure, oncogenic functions, and therapeutic potential

  2025influential citation
• Targeted Inhibition of CHD1L by OTI-611 Reprograms Chemotherapy and Targeted Therapy-Induced Cell Cycle Arrest and Suppresses Proliferation to Produce Synergistic Antitumor Effects in Breast and Colorectal Cancer

  2025cites this paper
• Targeting CHD1L suppresses prostate cancer progression via the FOXO3-PUMA axis

  2025cites this paper
• The validation of new CHD1L inhibitors as a therapeutic strategy for cancer

  2023cites this paper
• Molecular dynamics simulations reveal the inhibition mechanism of Cdc42 by RhoGDI1

  2023cites this paper
• A pan-cancer analysis reveals CHD1L as a prognostic and immunological biomarker in several human cancers

  2023cites this paper
• PARP1-SNAI2 transcription axis drives resistance to PARP inhibitor, Talazoparib

  2022cites this paper
• Hypermethylation of PRKCZ Regulated by E6 Inhibits Invasion and EMT via Cdc42 in HPV-Related Head and Neck Squamous Cell Carcinoma

  2022cites this paper
• The Design, Synthesis, and Biological Evaluation of the First Inhibitors of Oncogenic CHD1L

  2022cites this paper
• CHRIST: CD44-Incorporated Hepatocellular Carcinoma Risk Index Scoring Tool—A Novel Prognostic Scoring System for Hepatocellular Carcinoma Development and Aggressiveness

  2022cites this paper
• ARHGEF37 overexpression promotes extravasation and metastasis of hepatocellular carcinoma via directly activating Cdc42

  2022cites this paper
• CHD1L prevents lipopolysaccharide-induced hepatocellular carcinomar cell death by activating hnRNP A2/B1-nmMYLK axis

  2021cites this paper
• Effect of chromodomain helicase/ATPase DNA binding protein 1-like gene on the invasion and metastasis of tongue squamous cell carcinoma CAL27 cells.

  2021cites this paper
• The high expression of CHD1L and its clinical significance in human solid tumors

  2021cites this paper
• Epigenetic mechanisms of hepatocellular carcinoma progression: Potential therapeutic opportunities

  2021cites this paper
• Berberine Suppresses EMT in Liver and Gastric Carcinoma Cells through Combination with TGFβR Regulating TGF-β/Smad Pathway

  2021cites this paper
• CHD1L augments autophagy-mediated migration of hepatocellular carcinoma through targeting ZKSCAN3

  2021cites this paper
• The Landscape of lncRNAs in Hepatocellular Carcinoma: A Translational Perspective

  2021cites this paper
• Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer

  2021cites this paper
• Contribution of C3G and other GEFs to liver cancer development and progression

  2021cites this paper
• Structural basis of ALC1/CHD1L autoinhibition and the mechanism of activation by the nucleosome

  2021influential citation
• Diversity roles of CHD1L in normal cell function and tumorigenesis

  2021cites this paper
• Local control by salvage stereotactic body radiotherapy for recurrent/residual hepatocellular carcinoma after other local therapies

  2020cites this paper
• Effect of let-7c on the PI3K/Akt/FoxO signaling pathway in hepatocellular carcinoma

  2020cites this paper
• Mechanistic Insights into Regulation of the ALC1 Remodeler by the Nucleosome Acidic Patch

  2020cites this paper
• Effect of let ‐ 7 c on the PI 3 K / Akt / FoxO signaling pathway in hepatocellular carcinoma

  2020cites this paper
• CHD1L promotes EOC cell invasiveness and metastasis via the regulation of METAP2

  2020cites this paper
• Beneficial effects of Cripto-1 for transarterial chemoembolization in hepatocellular carcinoma

  2019cites this paper
• Myricetin inhibits migration and invasion of hepatocellular carcinoma MHCC97H cell line by inhibiting the EMT process

  2019influential citation
• CACYBP Enhances Cytoplasmic Retention of P27Kip1 to Promote Hepatocellular Carcinoma Progression in the Absence of RNF41 Mediated Degradation

  2019cites this paper
• Stem Cell Therapy for Hepatocellular Carcinoma: Future Perspectives.

  2019cites this paper
• An essential role of RNF187 in Notch1 mediated metastasis of hepatocellular carcinoma

  2019cites this paper
• Regulation of resection by chromatin associated proteins

  2019cites this paper
• CHD1L is associated with poor survival and promotes the proliferation and metastasis of intrahepatic cholangiocarcinoma

  2019influential citation
• Identification of novel alternative splicing isoform biomarkers and their association with overall survival in colorectal cancer

  2019cites this paper
• Dissociation mechanism of GDP from Cdc42 via DOCK9 revealed by molecular dynamics simulations

  2019cites this paper
• CHD 1 L promotes cell cycle progression and cell motility by up-regulating MDM 2 in breast cancer

  2019influential citation
• CHD1L contributes to cisplatin resistance by upregulating the ABCB1–NF-κB axis in human non-small-cell lung cancer

  2019cites this paper
• CHD1L promotes cell cycle progression and cell motility by up-regulating MDM2 in breast cancer.

  2019cites this paper
• Lymphoid enhancer-binding factor-1 promotes stemness and poor differentiation of hepatocellular carcinoma by directly activating the NOTCH pathway

  2019cites this paper
• Clinical significance of chromodomain helicase/ATPase DNA binding protein 1-like and human mutL homolog 1 gene expression in cholangiocarcinoma

  2018cites this paper
• Prognostic role of chromodomain helicase DNA binding protein 1-like protein in human solid cancers

  2018cites this paper
• The role of aberrant transcription factor expression and loss of epigenetic control in activating long-terminal-repeats in Hodgkin’s lymphoma

  2018cites this paper
• Identification of novel microRNA inhibiting actin cytoskeletal rearrangement thereby suppressing osteoblast differentiation

  2018cites this paper
• Hepatocellular Carcinoma: Causes, Mechanism of Progression and Biomarkers

  2018cites this paper
• A Novel Regulatory Axis, CHD1L-MicroRNA 486-Matrix Metalloproteinase 2, Controls Spermatogonial Stem Cell Properties

  2018cites this paper
• Hepatocellular expression of epithelial–mesenchymal transition markers in a sample of hepatitis C virus-infected Egyptian patients

  2018cites this paper
• Derepression of co-silenced tumor suppressor genes by nanoparticle-loaded circular ssDNA reduces tumor malignancy

  2018cites this paper
• Allosteric activation mechanism of a human oncogenic chromatin remodeler ALC1

  2018cites this paper
• Paving the Rho in cancer metastasis: Rho GTPases and beyond.

  2017cites this paper
• Polymeric immunoglobulin receptor promotes tumor growth in hepatocellular carcinoma

  2017cites this paper
• For robust big data analyses: a collection of 150 important pro-metastatic genes

  2017cites this paper
• Mechanistic Insights into Autoinhibition of the Oncogenic Chromatin Remodeler ALC1

  2017cites this paper
• CHD1L Expression Increases Tumor Progression and Acts as a Predictive Biomarker for Poor Prognosis in Pancreatic Cancer

  2017cites this paper
• A Poly-ADP-Ribose Trigger Releases the Auto-Inhibition of a Chromatin Remodeling Oncogene.

  2017cites this paper
• Overexpression of MUC13, a Poor Prognostic Predictor, Promotes Cell Growth by Activating Wnt Signaling in Hepatocellular Carcinoma.

  2017cites this paper
• Overexpression of CHD1L is associated with poor survival and aggressive tumor biology in esophageal carcinoma

  2017cites this paper
• CHD1L promotes lineage reversion of hepatocellular carcinoma through opening chromatin for key developmental transcription factors

  2016cites this paper
• CHD1L Regulates Cell Cycle, Apoptosis, and Migration in Glioma

  2016cites this paper
• Decreased Expression of EHD2 Promotes Tumor Metastasis and Indicates Poor Prognosis in Hepatocellular Carcinoma

  2016cites this paper
• A novel KLF6-Rho GTPase axis regulates hepatocellular carcinoma cell migration and dissemination

  2016cites this paper
• Cell adhesion induces overexpression of chromodomain helicase/ATPase DNA binding protein 1-like gene (CHD1L) and contributes to cell adhesion-mediated drug resistance (CAM-DR) in multiple myeloma cells.

  2016cites this paper
• SNF2H promotes hepatocellular carcinoma proliferation by activating the Wnt/β-catenin signaling pathway

  2016cites this paper
• Macrodomains: Structure, Function, Evolution, and Catalytic Activities.

  2016cites this paper
• Players in ADP-ribosylation: Readers and Erasers.

  2016cites this paper
• Morphine promotes cancer stem cell properties, contributing to chemoresistance in breast cancer

  2015cites this paper
• Ampli fi cation of Long Noncoding RNA ZFAS 1 Promotes Metastasis in Hepatocellular Carcinoma

  2015cites this paper
• Overexpression of N-terminal kinase like gene promotes tumorigenicity of hepatocellular carcinoma by regulating cell cycle progression and cell motility

  2015cites this paper
• Title Overexpression of N-terminal kinase like gene promotes tumorigenicity of hepatocellular carcinoma by regulating cell cycle progression and cell motility

  2015cites this paper
• STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells.

  2015cites this paper
• Chromodomain Helicase/ATPase DNA-Binding Protein 1-Like Gene (CHD1L) Expression and Implications for Invasion and Metastasis of Breast Cancer

  2015influential citation
• The interplay of NR4A receptors and the oncogene-tumor suppressor networks in cancer.

  2015cites this paper
• Downregulation of FOXP2 promoter human hepatocellular carcinoma cell invasion

  2015cites this paper
• Poly-ADP-ribosylation signaling during DNA damage repair.

  2015cites this paper
• Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival

  2015influential citation
• SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway

  2015cites this paper
• MiR-449a suppresses the epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by multiple targets

  2015cites this paper
• Amplification of Long Noncoding RNA ZFAS1 Promotes Metastasis in Hepatocellular Carcinoma.

  2015cites this paper
• Inter-kingdom Signaling by the Legionella Quorum Sensing Molecule LAI-1 Modulates Cell Migration through an IQGAP1-Cdc42-ARHGEF9-Dependent Pathway

  2015cites this paper
• Title Overexpression Of Chd 1 l Is Positively Associated With Metastasis Of Lung Adenocarcinoma And Predicts Patients Poor Survival

  2015cites this paper
• The Role of the Golgi Protein GM130 in Cell Polarity and Tumorigenesis

  2015cites this paper
• REGULATION OF ALC1'S SNF2 ATPASE: INTERPLAY BETWEEN THE SNF2 DOMAIN, THE MACRODOMAIN AND OTHER CONSERVED ELEMENTS

  2015cites this paper
• Systemic Delivery of MicroRNA-101 Potently Inhibits Hepatocellular Carcinoma In Vivo by Repressing Multiple Targets

  2015influential citation
• MicroRNA-9 promotes tumor metastasis via repressing E-cadherin in esophageal squamous cell carcinoma

  2014cites this paper
• Neutralizing murine TGFβR2 promotes a differentiated tumor cell phenotype and inhibits pancreatic cancer metastasis.

  2014cites this paper
• CD44 Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathologic Features

  2014cites this paper
• CHD1L is a novel independent prognostic factor for gastric cancer

  2014cites this paper
• Presence of CHD1L Over-Expression Is Associated with Aggressive Tumor Biology and Is a Novel Prognostic Biomarker for Patient Survival in Human Breast Cancer

  2014cites this paper
• The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update

  2014cites this paper
• PARP-1 activation regulates the DNA damage response to DNA double-strand breaks

  2014cites this paper
• Activating Transcription Factor 4 Promotes Esophageal Squamous Cell Carcinoma Invasion and Metastasis in Mice and Is Associated with Poor Prognosis in Human Patients

  2014cites this paper
• Maelstrom promotes hepatocellular carcinoma metastasis by inducing epithelial‐mesenchymal transition by way of Akt/GSK‐3β/Snail signaling

  2014cites this paper
• Analyse des propriétés oncogéniques de cIAP1 : contribution de ses partenaires cdc42 et E2F1

  2014cites this paper
• Upregulation of DNMT1 mediated by HBx suppresses RASSF1A expression independent of DNA methylation.

  2014cites this paper
• Cancer-associated fibroblasts in digestive tumors.

  2014cites this paper
• Desmocollin-2 〔DSC 2 〕基因抑制人類肺癌細胞的增生與移動能力 = Desmocollin-2 〔DSC 2 〕Inhibit proliferation and migration abi

  2014cites this paper
• Desmocollin-2 〔DSC 2 〕Inhibit proliferation and migration ability in human lung cancer cells

  2014cites this paper
• Loss of ARHGDIA expression is associated with poor prognosis in HCC and promotes invasion and metastasis of HCC cells.

  2014cites this paper
• Pathophysiology of HCC

  2014cites this paper
• Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma

  2014cites this paper